Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Huguette Lioté"'
Autor:
Kevin D. Deane, Eric L. Matteson, Leticia Kawano-Dourado, Yannick Allanore, René-Marc Flipo, Christophe Richez, Sébastien Ottaviani, David A. Schwartz, Karina Bonfiglioli, Montserrat I González-Pérez, Yurdagul Uzunhan, Gabriel Thabut, Jorge Rojas Serrano, Raphael Borie, Thierry Schaeverbeke, Benoit Wallaert, Ivan O. Rosas, Ramcés Falfán-Valencia, Lorenzo Cavagna, Marie-Elise Truchetet, Pascal Richette, Marco Sebastiani, Tracy J. Doyle, Emanuele Bozzalla Cassione, Gouri Koduri, Esther Ebstein, Jay H. Ryu, Lidwine Wemeau-Stervinou, Huguette Lioté, Dominique Valeyre, Pedro Rodríguez-Henriquez, Raphaël Porcher, Bruno Crestani, Jessica Lau, Steven Gazal, Marie-Christophe Boissier, Marie-Pierre Debray, Hilario Nunes, Mayra Mejía, Ivette Buendía-Roldán, Sylvain Marchand-Adam, Robert Vassallo, Andreina Teresa Manfredi, Nathalie Saidenberg-Kermanac’h, Joshua J. Solomon, Claire Dromer, Joyce S. Lee, Gloria Pérez-Rubio, Catherine Boileau, V. Michael Holers, Pierre-Antoine Juge, Marcio Valente Yamada Sawamura, Ronaldo Adib Kairalla, Caroline Kannengiesser, Philippe Dieudé
Publikováno v:
Eur Respir J
Background: Methotrexate (MTX) is a key anchor drug for rheumatoid arthritis (RA) management. Its use has been associated with hypersensitivity pneumonitis and diffuse lung disease. Whether MTX exposure increases the risk of interstitial lung disease
Autor:
Yaping Wang, Annick Clement, Nadia Nathan, Joanne J. van der Vis, Huguette Lioté, Aryeh Fischer, Dominique Valeyre, David A. Schwartz, Jan C. Grutters, Timothy B Niewold, Michael A. Nalls, Ivette Buendía-Roldán, Dimitrios Boumpas, Vincent Cottin, Marie-Christophe Boissier, Theofanis Karageorgas, Mayra Mejía, Yaël A de Man, Kevin D. Deane, Effrosyni D. Manali, Katarina M. Antoniou, Joshua J. Solomon, Jay H. Ryu, Pierre-Antoine Juge, Martin Soubrier, Jean Sibilia, Hilario Nunes, Marie-Pierre Debray, Christophe Richez, Spyros Papiris, Steven Gazal, Catherine Boileau, Deborah Assayag, Nathalie Saidenberg-Kermanac’h, Tasha E. Fingerlin, Claire Dromer, Marvin I. Schwarz, Esther Ebstein, Michael Holers, Tracy J. Doyle, Ivan O. Rosas, Bruno Crestani, Hiroshi Furukawa, Evgenia Dobrinskikh, Cornelis Blauwendraat, Paul J. Wolters, Naoyuki Tsuchiya, Thierry Schaeverbeke, Ramcés Falfán-Valencia, Lidwine Wemeau-Stervinou, Gabriel Thabut, Shigeto Tohma, Coline H.M. van Moorsel, Montserrat I González-Pérez, Andrew J. Gross, Benoit Wallaert, Shomi Oka, Caroline Kannengiesser, Joyce S. Lee, Enrique Ambrocio-Ortiz, Aline Frazier, Sylvain Marchand-Adam, René-Marc Flipo, Eric L. Matteson, Pascal Richette, S. Amselem, Raphael Borie, Jorge Rojas-Serrano, Yannick Allanore, Sébastien Ottaviani, Philippe Dieudé, Avram D Walts
Publikováno v:
New England Journal of Medicine
New England Journal of Medicine, 2018, 379 (23), pp.2209-2219. ⟨10.1056/NEJMoa1801562⟩
New England Journal of Medicine, Massachusetts Medical Society, 2018, 379 (23), pp.2209-2219. ⟨10.1056/NEJMoa1801562⟩
New England Journal of Medicine, 2018, 379 (23), pp.2209-2219. ⟨10.1056/NEJMoa1801562⟩
New England Journal of Medicine, Massachusetts Medical Society, 2018, 379 (23), pp.2209-2219. ⟨10.1056/NEJMoa1801562⟩
International audience; BACKGROUND: Given the phenotypic similarities between rheumatoid arthritis (RA)-associated interstitial lung disease (ILD) (hereafter, RA-ILD) and idiopathic pulmonary fibrosis, we hypothesized that the strongest risk factor f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2680cddcf56c79c5c08f0bd779c5bcd8
https://univ-lyon1.hal.science/hal-02191891
https://univ-lyon1.hal.science/hal-02191891
Autor:
Steven Gazal, Hilario Nunes, Jean Sibilia, Christelle Ménard, Aurélien Justet, Philippe Dieudé, Isabelle Callebaut, Amélie Bonnefond, Martin Soubrier, Patrick Revy, Catherine Boileau, Pierre-Antoine Juge, Thierry Schaeverbeke, Aline Frazier, Nathalie Saidenberg, Sébastien Ottaviani, Nadia Nathan, Bruno Crestani, Christophe Béroud, Baptiste Coustet, Vincent Cottin, Lidwine Wemeau-Stervinou, Jean-Pierre Desvignes, Marie-Christophe Boissier, Florence Dastot-Le Moal, Serge Amselem, Philippe Froguel, Yannick Allanore, Annick Clement, Olivier Sand, Gabriel Thabut, Marie-Pierre Debray, Pascal Richette, Caroline Kannengiesser, Benoit Wallaert, Christophe Richez, Dominique Valeyre, Sylvain Marchand-Adam, Huguette Lioté, Nicolas Leulliot, René-Marc Flipo, Raphael Borie, Claire Dromer, David Salgado
Publikováno v:
European Respiratory Journal
European Respiratory Journal, 2017, 49 (5), ⟨10.1183/13993003.02314-2016⟩
European Respiratory Journal, European Respiratory Society, 2017, 49 (5), 〈10.1183/13993003.02314-2016〉
European Respiratory Journal, European Respiratory Society, 2017, 49 (5), ⟨10.1183/13993003.02314-2016⟩
European Respiratory Journal, 2017, 49 (5), ⟨10.1183/13993003.02314-2016⟩
European Respiratory Journal, European Respiratory Society, 2017, 49 (5), 〈10.1183/13993003.02314-2016〉
European Respiratory Journal, European Respiratory Society, 2017, 49 (5), ⟨10.1183/13993003.02314-2016⟩
Despite its high prevalence and mortality, little is known about the pathogenesis of rheumatoid arthritis-associated interstitial lung disease (RA-ILD). Given that familial pulmonary fibrosis (FPF) and RA-ILD frequently share the usual pattern of int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1863204c1a5b694157b195da987690d6
https://hal.science/hal-01595463
https://hal.science/hal-01595463
Publikováno v:
European Respiratory Journal. 35:681-687
The anti-CD20 antibody rituximab has been reported to induce a heterogeneous spectrum of lung disorders. The aim of the present study was to critically review data on the clinical presentations, causality assessments and management strategies of lung
Autor:
Sylvain Marchand-Adam, Christophe Béroud, Huguette Lioté, Nicolas Leulliot, Christelle Ménard, Nadia Nathan, Aline Frazier, P. Richette, Benoit Wallaert, J. Sibilia, Patrick Revy, Martin Soubrier, Steven Gazal, Bruno Crestani, Sébastien Ottaviani, Jean-Pierre Desvignes, Hilario Nunes, S. Amselem, Y. Allanore, Dominique Valeyre, N. Saidenberg, Aurélien Justet, Gabriel Thabut, Annick Clement, Vincent Cottin, Olivier Sand, Christophe Richez, P.A. Juge, Philippe Froguel, Catherine Boileau, Isabelle Callebaut, R.M. Flipo, T. Schaeverbeke, Amélie Bonnefond, Marie-Christophe Boissier, Marie-Pierre Debray, Baptiste Coustet, Philippe Dieudé, F. Dastot Le Moal, Caroline Kannengiesser, Lidwine Wemeau-Stervinou, Raphael Borie, Claire Dromer, David Salgado
Publikováno v:
Revue du Rhumatisme. 83:A91-A92
Introduction La pneumopathie interstitielle diffuse (PID) est l’une des causes majeure de mortalite chez les patients atteints de polyarthrite rhumatoide (PR). Malgre une prevalence et une mortalite importante, la physiopathologie de la PID associe
Autor:
Eric Oksenhendler, Marie Wislez, Marie-France Carette, Jacques Cadranel, Mathilde Sibony, Huguette Lioté, Jean-Marc Naccache
Publikováno v:
Respiration. 67:467-470
A 68-year-old woman suffering from common variable immunodeficiency (CVI) developed a typical picture of organizing pneumonia. Causative factors other than CVI were eliminated. Several antibiotic regimens failed to improve the patient’s condition,
Autor:
Huguette Lioté
Publikováno v:
Joint Bone Spine. 75:260-262
Autor:
Huguette Lioté
Publikováno v:
Revue du Rhumatisme. 75:385-387
Autor:
Thierry Bienvenu, Serge Amselem, Aleksander Edelman, Baya Cherif-Zahar, Philippe Duquesnoy, Jordi Ehrenfeld, Marion Viel, Huguette Lioté, Nicolette Farman, Gabrielle Planelles, Isabelle Sermet-Gaudelus, Delphine Roussel, Annick Thomas, Naziha Bakouh, Rola Abou Taam
Publikováno v:
Human Mutation
Human Mutation, 2013, 34 (10), pp.1404-1414. ⟨10.1002/humu.22382⟩
Human Mutation, 2013, 34 (10), pp.1404-1414. ⟨10.1002/humu.22382⟩
Diffuse bronchiectasis is a common problem in respiratory clinics. We hypothesized that mutations in the solute carrier 26A9 (SLC26A9) gene, encoding for a chloride (Cl(-)) transporter mainly expressed in lungs, may lead to defects in mucociliary cle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60fb71e6e9557043e92fd02fb589fa0c
https://www.hal.inserm.fr/inserm-03885353
https://www.hal.inserm.fr/inserm-03885353
Autor:
Frédéric Lioté, Huguette Lioté
Publikováno v:
Joint bone spine. 78(4)
TNF-α antagonist therapy is associated with a risk of severe, extrapulmonary, disseminated tuberculosis, which is fatal in 10% of cases. The risk of tuberculosis is increased four-fold in patients on TNF-α antagonist therapy. The main risk factors